Global Nuclear Medicine Competitive Landscape Professional Research Report 2025

Global Nuclear Medicine Competitive Landscape Professional Research Report 2025

Research Summary

Nuclear medicine is a medical specialty that utilizes small amounts of radioactive substances, known as radiopharmaceuticals, to diagnose, treat, and monitor diseases. It combines molecular biology, nuclear physics, and medical imaging techniques to provide valuable information about the functioning and structure of organs and tissues in the body. In diagnostic nuclear medicine procedures, patients are administered radiopharmaceuticals either orally, by injection, or by inhalation. These substances emit gamma rays or positrons, which are then detected by specialized imaging devices such as gamma cameras or positron emission tomography (PET) scanners. The captured data is processed to create detailed images that highlight areas of abnormal function or metabolism. Nuclear medicine is particularly useful in the diagnosis and staging of various conditions, including cancer, heart disease, neurological disorders, and thyroid disorders. It also plays a role in therapeutic applications, such as targeted radiation therapy for certain cancers. Nuclear medicine techniques offer valuable insights into the physiological processes within the body, enabling physicians to make more accurate diagnoses, tailor treatment plans, and monitor treatment effectiveness.

According to DIResearch's in-depth investigation and research, the global Nuclear Medicine market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Nuclear Medicine include GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Triad Isotopes, Jubilant Pharma, Nordion, Eli Lilly, SIEMENS, China Isotope & Radiation, Dongcheng Pharmaceutical Group etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Nuclear Medicine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Nuclear Medicine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Nuclear Medicine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Nuclear Medicine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Nuclear Medicine Include:

GE Healthcare

Bracco Imaging

Mallinckrodt

Lantheus Medical Imaging

Bayer

Triad Isotopes

Jubilant Pharma

Nordion

Eli Lilly

SIEMENS

China Isotope & Radiation

Dongcheng Pharmaceutical Group

Nuclear Medicine Product Segment Include:

Tc-99

I-123/131

In-111

Xe-133

Th-201

Ga-67

Others

Nuclear Medicine Product Application Include:

Diagnostic

Therapeutic

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Nuclear Medicine Industry PESTEL Analysis

Chapter 3: Global Nuclear Medicine Industry Porter’s Five Forces Analysis

Chapter 4: Global Nuclear Medicine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Nuclear Medicine Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Nuclear Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Nuclear Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Nuclear Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Nuclear Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Nuclear Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Nuclear Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Nuclear Medicine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources